Moderna announces clinical update on bivalent covid-19 booster platform
Moderna's first bivalent booster vaccine candidate, mrna-1273.211, demonstrated superior neutralizing titers compared to mrna-1273 against all variants of concern, including omicron; superiority was maintained for six months after booster for the beta and omicron variants tolerability and safety of the bivalent booster were consistent with authorized 50 Μg mrna-1273 booster moderna is evaluating an updated bivalent booster incorporating more omicron-specific mutations (mrna-1273.214) in a phase 2/3 clinical study; initial data on this candidate, expected in the second quarter, will inform selection of fall 2022 booster for northern hemisphere cambridge, ma / accesswire / april 19, 2022 / moderna, inc., (nasdaq:mrna) a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines today announced new clinical data on its bivalent covid-19 booster platform including data on the company's first bivalent booster candidate, mrna-1273.211, which includes mutations found in the beta variant of concern, several of which have been persistent in more recent variants of concern including omicron. a 50 Μg booster dose of mrna-1273.211 demonstrated superiority against beta, delta and omicron variants of concern one month after administration.
MRNA Ratings Summary
MRNA Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission